Revenue
2019
2020
2021
2022
2023
2024
2025
Oscar Health, Inc. (OSCR)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $28.6M | $20.6M | $21.4M | $64.9M | $5.4M | $0 | $488.2M |
| Operating income | −$396.4M | $57.3M | −$235.6M | −$589.9M | −$544.5M | −$402.3M | −$259.4M |
| EBITDAderived | −$367.5M | $89.4M | −$204.9M | −$574.6M | −$529.9M | −$391.0M | −$252.5M |
| Net income | −$443.2M | $25.4M | −$270.7M | −$606.3M | −$572.6M | −$406.8M | −$261.2M |
| Basic EPSper diluted share | -$1.69 | $0.11 | -$1.22 | -$2.85 | -$3.20 | -$14.16 | -$9.06 |
| Diluted EPSper diluted share | -$1.69 | $0.10 | -$1.22 | -$2.85 | -$3.20 | -$14.16 | -$9.06 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 · 10b5-1 | Bertolini Mark TChief Executive Officer | SellClass A Common Stock | 149.8K | $29.79 | $4.46M | 8.99M |
| Jun 26, 2026Form 4 · 10b5-1 | Bertolini Mark TChief Executive Officer | SellClass A Common Stock | 441.4K | $29.11 | $12.85M | 9.14M |
| Jun 25, 2026Form 4 · 10b5-1 | Bertolini Mark TChief Executive Officer | SellClass A Common Stock | 17.2K | $29.08 | $500.2K | 9.58M |
| Jun 25, 2026Form 4 · 10b5-1 | Bertolini Mark TChief Executive Officer | SellClass A Common Stock | 597.9K | $28.60 | $17.10M | 9.60M |
| Jun 23, 2026Form 4 · 10b5-1 | Schlosser MarioDirector | SellClass A Common Stock · indirect | 97 | $30.09 | $2.9K | 0 |